1. RETRACTED ARTICLE: β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor-β arrestin scaffold-mediated activation of extracellular-regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra-neuraxial carcinoma
   George Zaki Ghali et al, 2020, Molecular Biology Reports CrossRef
2. Mitigation Effect of Proanthocyanidin on Secondary Heart Injury in Rats Caused by Mechanical Trauma
   Shuo Ma et al, 2017, Scientific Reports CrossRef
3. Oligomer procyanidins (F2) repress HIF-1α expression in human U87 glioma cells by inhibiting the EGFR/ AKT/mTOR and MAPK/ERK1/2 signaling pathways in vitro and in vivo
   Hong-Li Zheng et al, 2017, Oncotarget CrossRef
4. Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling
   D. Lynn Kirkpatrick et al, 2017, Antioxidants & Redox Signaling CrossRef
5. Proanthocyanidins as a Potential Novel Way for the Treatment of Hemangioma
   Ran Tang et al, 2021, BioMed Research International CrossRef
6. Purification and characterization of Se‐enriched Grifola frondosa glycoprotein, and evaluating its amelioration effect on As3+‐induced immune toxicity
   Zhe‐Han Zhang et al, 2022, Journal of the Science of Food and Agriculture CrossRef
7. Procyanidin B2 gallate regulates TNF-α production from T cells through inhibiting glycolytic activity via mTOR-HIF-1 pathway
   Katsunori Endo et al, 2020, Biochemical Pharmacology CrossRef
8. Remodeling the blood–brain barrier microenvironment by natural products for brain tumor therapy
   Xiao Zhao et al, 2017, Acta Pharmaceutica Sinica B CrossRef
9. Higher than normal mitochondrial DNA content associated with better outcome in acute promyelocytic leukaemia? Maybe
   Peter H. Wiernik, 2023, British Journal of Haematology CrossRef
10. Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer
    Taofeek K. Owonikoko et al, 2016, Journal of Translational Medicine CrossRef
11. Natural products: a hope for glioblastoma patients
    Raghupathy Vengoji et al, 2018, Oncotarget CrossRef
12. Potential anti-cancer activity of Moringa oleifera derived bio-active compounds targeting hypoxia-inducible factor-1 alpha in breast cancer
    Neha Masarkar et al, 2023, Journal of Complementary and Integrative Medicine CrossRef
13. Bioactive compounds from Actinidia arguta fruit as a new strategy to fight glioblastoma
    Catarina Macedo et al, 2024, Food Research International CrossRef
14. Cellular senescence: Silent operator and therapeutic target in cancer
    Deepika Ramu et al, 2021, IUBMB Life CrossRef
15. Mechanistic insights into anticancer properties of oligomeric proanthocyanidins from grape seeds in colorectal cancer
    Preethi Ravindranathan et al, 2018, Carcinogenesis CrossRef
16. Trisenox induces cytotoxicity through phosphorylation of mitogen‐activated protein kinase molecules in acute leukemia cells
    Sanjay Kumar et al, 2018, Journal of Biochemical and Molecular Toxicology CrossRef
17. Therapeutic potential of natural products in glioblastoma treatment: targeting key glioblastoma signaling pathways and epigenetic alterations
    M. N. Abbas et al, 2020, Clinical and Translational Oncology CrossRef
18. Carnosine suppresses human colorectal cancer cell proliferation by inducing necroptosis and autophagy and reducing angiogenesis
    Shu-Ling Hsieh et al, 2021, Oncology Letters CrossRef
19. miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells
    Mrinmay Chakrabarti et al, 2016, PLOS ONE CrossRef
20. Targeting PI3K/Akt/mTOR signaling pathway by polyphenols: Implication for cancer therapy
    Mohammad Mirza-Aghazadeh-Attari et al, 2020, Life Sciences CrossRef
21. Targeting angiogenesis in gliomas: Potential role of phytochemicals
    Mehdi Sanati et al, 2022, Journal of Functional Foods CrossRef
22. Survivin isoform expression in arsenic trioxide‐treated acute promyelocytic leukemia cell line and patients: The odd expression pattern of survivin‐2α
    Majid Zaki Dizaji et al, 2017, Asia-Pacific Journal of Clinical Oncology CrossRef